Cargando…
Specific Sialoforms Required for the Immune Suppressive Activity of Human Soluble CD52
Human CD52 is a small glycopeptide (12 amino acid residues) with one N-linked glycosylation site at asparagine 3 (Asn3) and several potential O-glycosylation serine/threonine sites. Soluble CD52 is released from the surface of activated T cells and mediates immune suppression via its glycan moiety....
Autores principales: | Shathili, Abdulrahman M., Bandala-Sanchez, Esther, John, Alan, Goddard-Borger, Ethan D., Thaysen-Andersen, Morten, Everest-Dass, Arun V., Adams, Timothy E., Harrison, Leonard C., Packer, Nicolle H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719568/ https://www.ncbi.nlm.nih.gov/pubmed/31507595 http://dx.doi.org/10.3389/fimmu.2019.01967 |
Ejemplares similares
-
Complementary LC-MS/MS-Based N-Glycan, N-Glycopeptide, and Intact N-Glycoprotein Profiling Reveals Unconventional Asn71-Glycosylation of Human Neutrophil Cathepsin G
por: Loke, Ian, et al.
Publicado: (2015) -
Trends in oligomannosylation and α1,2-mannosidase expression in human cancers
por: Chatterjee, Sayantani, et al.
Publicado: (2021) -
The Hitchhiker's guide to glycoproteomics
por: Oliveira, Tiago, et al.
Publicado: (2021) -
CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function
por: Bandala-Sanchez, Esther, et al.
Publicado: (2018) -
Differential Site Accessibility Mechanistically Explains Subcellular-Specific N-Glycosylation Determinants
por: Lee, Ling Yen, et al.
Publicado: (2014)